Ligand stimulation of CD95 induces activation of Plk3 followed by phosphorylation of caspase-8

Cell Signaling by Receptor Tyrosine Kinases

Lemmon, M. A., & Schlessinger, J. (2010) · Cell · doi:10.1016/j.cell.2010.06.011 · Cited by 7,929 · see citing works

FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex

Muzio, M., Chinnaiyan, A. M., Kischkel, F. C., O'Rourke, K., Shevchenko, A., Ni, J., Scaffidi, C., Bretz, J. D., Zhang, M., Gentz, R., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81266-0 · Cited by 3,046 · see citing works

Two CD95 (APO‐1/Fas) signaling pathways

Scaffidi, C., Fulda, S., Srinivasan, A., Friesen, C., Li, F., Tomaselli, K. J., Debatin, K., Krammer, P. H., & Peter, M. E. (1998) · The EMBO Journal · doi:10.1093/emboj/17.6.1675 · Cited by 3,000 · see citing works

Targeting cancer with small molecule kinase inhibitors

Zhang, J., Yang, P. L., & Gray, N. S. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2559 · Cited by 2,585 · see citing works

Involvement of MACH, a Novel MORT1/FADD-Interacting Protease, in Fas/APO-1- and TNF Receptor–Induced Cell Death

Boldin, M. P., Goncharov, T. M., Goltseve, Y. V., & Wallach, D. (1996) · Cell · doi:10.1016/s0092-8674(00)81265-9 · Cited by 2,292 · see citing works

Cytotoxicity‐dependent APO‐1 (Fas/CD95)‐associated proteins form a death‐inducing signaling complex (DISC) with the receptor.

Kischkel, F. C., Hellbardt, S., Behrmann, I., Germer, M., Pawlita, M., Krammer, P. H., & Peter, M. E. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00245.x · Cited by 2,181 · see citing works

Lethal effect of the anti-Fas antibody in mice

Ogasawara, J., Watanabe-Fukunaga, R., Adachi, M., Matsuzawa, A., Kasugai, T., Kitamura, Y., Itoh, N., Suda, T., & Nagata, S. (1993) · Nature · doi:10.1038/364806a0 · Cited by 1,881 · see citing works

Monoclonal Antibody-Mediated Tumor Regression by Induction of Apoptosis

Trauth, B. C., Klas, C., Peters, A. M. J., Matzku, S., Mӧller, P., Falk, W., Debatin, K., & Krammer, P. H. (1989) · Science · doi:10.1126/science.2787530 · Cited by 1,716 · see citing works

FLICE is activated by association with the CD95 death‐inducing signaling complex (DISC)

Medema, J. P., Scaffidi, C., Kischkel, F. C., Shevchenko, A., Mann, M., Krammer, P. H., & Peter, M. E. (1997) · The EMBO Journal · doi:10.1093/emboj/16.10.2794 · Cited by 1,189 · see citing works

The CD95(APO-1/Fas) DISC and beyond

Peter, M. E., & Krammer, P. H. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401186 · Cited by 1,075 · see citing works

An Induced Proximity Model for Caspase-8 Activation

Muzio, M., Stockwell, B. R., Stennicke, H. R., Salvesen, G. S., & Dixit, V. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.5.2926 · Cited by 1,023 · see citing works

Targeting polo-like kinase 1 for cancer therapy

Strebhardt, K., & Ullrich, A. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1841 · Cited by 843 · see citing works

The Molecular Basis for Phosphodependent Substrate Targeting and Regulation of Plks by the Polo-Box Domain

Elia, A. E. H., Rellos, P., Haire, L. F., Chao, J. W., Ivins, F. J., Hoepker, K., Mohammad, D. H., Cantley, L. C., Smerdon, S. J., & Yaffe, M. B. (2003) · Cell · doi:10.1016/s0092-8674(03)00725-6 · Cited by 767 · see citing works

Mitochondria: master regulators of danger signalling

Galluzzi, L., Kepp, O., & Kroemer, G. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3479 · Cited by 733 · see citing works

Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy

Strebhardt, K. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3184 · Cited by 657 · see citing works

RIP3 Induces Apoptosis Independent of Pronecrotic Kinase Activity

Mandal, P., Berger, S. B., Pillay, S., Moriwaki, K., Huang, C., Guo, H., Lich, J. D., Finger, J. N., Kasparcova, V., Votta, B. J., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.10.021 · Cited by 619 · see citing works

TRANCE, a TNF Family Member, Activates Akt/PKB through a Signaling Complex Involving TRAF6 and c-Src

Wong, B. R., Besser, D., Kim, N., Arron, J. R., Vologodskaia, M., Hanafusa, H., & Choi, Y. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80232-4 · Cited by 593 · see citing works

Death Receptor Recruitment of Endogenous Caspase-10 and Apoptosis Initiation in the Absence of Caspase-8

Kischkel, F. C., Lawrence, D. A., Tinel, A., LeBlanc, H. N., Virmani, A. K., Schow, P. W., Gazdar, A. F., Blenis, J., Arnott, D. P., & Ashkenazi, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105102200 · Cited by 536 · see citing works

Polo-like kinases: structural variations lead to multiple functions

Zitouni, S., Nabais, C., Jana, S. C., Guerrero, A., & Bettencourt‐Dias, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3819 · Cited by 494 · see citing works

Getting TRAIL back on track for cancer therapy

Lemke, J., von Karstedt, S., Zinngrebe, J., & Walczak, H. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.81 · Cited by 455 · see citing works

The CD95 Receptor: Apoptosis Revisited

Peter, M. E., Budd, R. C., Desbarats, J., Hedrick, S. Μ., Hueber, A., Newell, M. K., Owen, L. B., Pope, R. M., Tschopp, J. F., Wajant, H., et al. (2007) · Cell · doi:10.1016/j.cell.2007.04.031 · Cited by 396 · see citing works

PHOSIDA 2011: the posttranslational modification database

Gnad, F., Gunawardena, J., & Mann, M. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq1159 · Cited by 379 · see citing works

Polo-like kinases and oncogenesis

Eckerdt, F., Yuan, J., & Strebhardt, K. (2005) · Oncogene · doi:10.1038/sj.onc.1208273 · Cited by 363 · see citing works

Effect of RNA Silencing of Polo-Like Kinase-1 (PLK1) on Apoptosis and Spindle Formation in Human Cancer Cells

Spänkuch, B., Bereiter‐Hahn, J., Kaufmann, M., & Strebhardt, K. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.24.1863 · Cited by 330 · see citing works

Regulation of ubiquitin-binding proteins by monoubiquitination

Hoeller, D., Crosetto, N., Blagoev, B., Raiborg, C., Tikkanen, R., Wagner, S., Kowanetz, K., Rainer Breitling, A., Mann, M., Stenmark, H., et al. (2006) · Nature Cell Biology · doi:10.1038/ncb1354 · Cited by 314 · see citing works

Yes and PI3K Bind CD95 to Signal Invasion of Glioblastoma

Kleber, S., Sancho-Martinez, I., Wiestler, B., Beisel, A., Gieffers, C., Hill, O., Thiemann, M., Mueller, W., Sykora, J., Kuhn, A., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.02.003 · Cited by 309 · see citing works

Induction and down-regulation of PLK, a humanserine/threonine kinase expressed in proliferating cells andtumors.

Holtrich, U., Wolf, G., Bräuninger, A., Karn, T., Böhme, B., Rübsamen‐Waigmann, H., & Strebhardt, K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.5.1736 · Cited by 276 · see citing works

Malignant Transformation of Mammalian Cells Initiated by Constitutive Expression of thePolo-like Kinase1

Smith, M. R., Wilson, M. L., Hamanaka, R., Chase, D., Kung, H., Longo, D. L., & Ferris, D. K. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6633 · Cited by 249 · see citing works

Mutation of the polo-box disrupts localization and mitotic functions of the mammalian polo kinase Plk

Lee, K. S., Grenfell‐Lee, T. Z., Yarm, F. R., & Erikson, R. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9301 · Cited by 245 · see citing works

Plk3 Functionally Links DNA Damage to Cell Cycle Arrest and Apoptosis at Least in Part via the p53 Pathway

Xie, S., Wu, H., Wang, Q., Cogswell, J. P., Husain, I., Conn, C. W., Stambrook, P. J., Jhanwar‐Uniyal, M., & Dai, W. H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106050200 · Cited by 226 · see citing works

Phosphorylation of Threonine 210 and the Role of Serine 137 in the Regulation of Mammalian Polo-like Kinase

Jang, Y.-J., Ma, S., Terada, Y., & Erikson, R. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202172200 · Cited by 221 · see citing works

p38-MAPK Signals Survival by Phosphorylation of Caspase-8 and Caspase-3 in Human Neutrophils

Alvarado-Kristensson, M., Melander, F., Leandersson, K., Rönnstrand, L., Wernstedt, C., & Andersson, T. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031771 · Cited by 213 · see citing works

Src kinase phosphorylates Caspase‐8 on Tyr380: a novel mechanism of apoptosis suppression

Cursi, S., Rufini, A., Stagni, V., Condò, I., Matafora, V., Bachi, A., Bonifazi, A. P., Coppola, L., Superti‐Furga, G., Testi, R., et al. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601085 · Cited by 205 · see citing works

Targeting Polo-Like Kinases: A Promising Therapeutic Approach for Cancer Treatment

Liu, X. (2015) · Translational Oncology · doi:10.1016/j.tranon.2015.03.010 · Cited by 172 · see citing works

It cuts both ways: reconciling the dual roles of caspase 8 in cell death and survival

Oberst, A., & Green, D. R. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3214 · Cited by 157 · see citing works

Downregulation of human polo-like kinase activity by antisense oligonucleotides induces growth inhibition in cancer cells

Spänkuch, B., Wolf, G., Solbach, C., Loibl, S., Knecht, R., Stegmüller, M., von Minckwitz, G., Kaufmann, M., & Strebhardt, K. (2002) · Oncogene · doi:10.1038/sj.onc.1205412 · Cited by 149 · see citing works

prk, a Cytokine-inducible Human Protein Serine/Threonine Kinase Whose Expression Appears to be Down-regulated in Lung Carcinomas

Li, B., Ouyang, B., Pan, H., Reissmann, P. T., Slamon, D. J., Arceci, R. J., Lu, L., & Dai, W. H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19402 · Cited by 145 · see citing works

Tumor-specific cytotoxic T lymphocyte activity determines colorectal cancer patient prognosis

Reißfelder, C., Stamova, S., Gossmann, C., Braun, M., Bonertz, A., Walliczek, U., Grimm, M., Rahbari, N. N., Koch, M., Saadati, M., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74894 · Cited by 142 · see citing works

Stable gene silencing of cyclin B1 in tumor cells increases susceptibility to taxol and leads to growth arrest in vivo

Yuan, J., Krämer, A., Matthess, Y., Yan, R., Spänkuch, B., Gätje, R., Knecht, R., Kaufmann, M., & Strebhardt, K. (2005) · Oncogene · doi:10.1038/sj.onc.1209202 · Cited by 128 · see citing works

Structural basis for the inhibition of Polo-like kinase 1

Xu, J., Shen, C., Wang, T., & Quan, J. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2623 · Cited by 127 · see citing works

Cell Cycle Arrest and Apoptosis Induced by Human Polo-Like Kinase 3 Is Mediated through Perturbation of Microtubule Integrity

Wang, Q., Xie, S., Chen, J., Fukasawa, K., Naik, U. P., Traganos, F., Darżynkiewicz, Z., Jhanwar‐Uniyal, M., & Dai, W. H. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.10.3450-3459.2002 · Cited by 124 · see citing works

mRNA turnover rate limits siRNA and microRNA efficacy

Larsson, E., Sander, C., & Marks, D. (2010) · Molecular Systems Biology · doi:10.1038/msb.2010.89 · Cited by 120 · see citing works

Cdk1/Cyclin B1 Controls Fas-Mediated Apoptosis by Regulating Caspase-8 Activity

Matthess, Y., Raab, M., Sanhaji, M., Lavrik, I. N., & Strebhardt, K. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00731-10 · Cited by 105 · see citing works

The role of Plk3 in oncogenesis

Helmke, C., Becker, S., & Strebhardt, K. (2015) · Oncogene · doi:10.1038/onc.2015.105 · Cited by 94 · see citing works

Human papillomavirus DNA load and p16INK4aexpression predict for local control in patients with anal squamous cell carcinoma treated with chemoradiotherapy

Rödel, F., Wieland, U., Fraunholz, I. B., Kitz, J., Rave‐Fränk, M., Wolff, H. A., Weiß, C., Wirtz, R., Balermpas, P., Fokas, E., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28979 · Cited by 89 · see citing works

Toxicity modelling of Plk1-targeted therapies in genetically engineered mice and cultured primary mammalian cells

Raab, M., Kappel, S., Krämer, A., Sanhaji, M., Matthess, Y., Kurunci‐Csacsko, E., Calzada‐Wack, J., Rathkolb, B., Rozman, J., Adler, T., et al. (2011) · Nature Communications · doi:10.1038/ncomms1395 · Cited by 85 · see citing works

Polo kinase and progression through M phase in Drosophila: a perspective from the spindle poles

Glover, D. M. (2005) · Oncogene · doi:10.1038/sj.onc.1208279 · Cited by 84 · see citing works

Incomplete cytokinesis and induction of apoptosis by overexpression of the mammalian polo-like kinase, Plk3.

Conn, C. W., Hennigan, R. F., Dai, W. H., Sánchez, Y., & Stambrook, P. J. (2000) · PubMed · Cited by 81 · see citing works

A genome-wide RNAi screen reveals multiple regulators of caspase activation

Yi, C. H., Sogah, D. K., Boyce, M., Degterev, A., Christofferson, D. E., & Yuan, J. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200708090 · Cited by 80 · see citing works

Sequestration of Polo kinase to microtubules by phosphopriming-independent binding to Map205 is relieved by phosphorylation at a CDK site in mitosisPreprint

Archambault, V., D’Avino, P. P., Deery, M. J., Lilley, K. S., & Glover, D. M. (2008) · Genes & Development · doi:10.1101/gad.486808 · Cited by 73 · see citing works

Polo-Like Kinase 1: Target and Regulator of Transcriptional Control

Martin, B. T., & Strebhardt, K. (2006) · Cell Cycle · doi:10.4161/cc.5.24.3538 · Cited by 72 · see citing works

Sequential Cdk1 and Plk1 phosphorylation of caspase‐8 triggers apoptotic cell death during mitosis

Matthess, Y., Raab, M., Knecht, R., Becker, S., & Strebhardt, K. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2013.12.013 · Cited by 71 · see citing works

CD95 in cancer: tool or target?

Martín-Villalba, A., Llorens-Bobadilla, E., & Wollny, D. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.03.002 · Cited by 68 · see citing works

PRK, a cell cycle gene localized to 8p21, is downregulated in head and neck cancer

Dai, W. H., Li, Y., Ouyang, B., Pan, H., Reissmann, P. T., Li, J., Wiest, J. S., Stambrook, P. J., Gluckman, J. L., Noffsinger, A. E., et al. (2000) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(200003)27:3 · Cited by 67 · see citing works

Tumor‐infiltrating CD8+ T lymphocytes associated with clinical outcome in anal squamous cell carcinoma

Hu, W., Miyai, K. N., Cajas-Monson, L. C., Luo, L., Liu, L., & Ramamoorthy, S. L. (2015) · Journal of Surgical Oncology · doi:10.1002/jso.23998 · Cited by 66 · see citing works

Adhesion induced expression of the serine/threonine kinase Fnk in human macrophages

Holtrich, U., Wolf, G., Yuan, J., Bereiter‐Hahn, J., Karn, T., Weiler, M., Kauselmann, G., Rehli, M., Andreesen, R., Kaufmann, M., et al. (2000) · Oncogene · doi:10.1038/sj.onc.1203845 · Cited by 64 · see citing works

Yeast polo-like kinases: functionally conserved multitask mitotic regulators

Lee, K. S., Park, J., Asano, S., & Park, C. J. (2005) · Oncogene · doi:10.1038/sj.onc.1208271 · Cited by 64 · see citing works

PADI4 acts as a coactivator of Tal1 by counteracting repressive histone arginine methylation

Kolodziej, S., Kuvardina, O. N., Oellerich, T., Herglotz, J., Backert, I., Kohrs, N., la Buscató, E., Wittmann, S. K., Salinas, G., Bonig, H. B., et al. (2014) · Nature Communications · doi:10.1038/ncomms4995 · Cited by 62 · see citing works

Polo Box Domain of Plk3 Functions as a Centrosome Localization Signal, Overexpression of Which Causes Mitotic Arrest, Cytokinesis Defects, and Apoptosis

Jiang, N., Wang, X., Jhanwar‐Uniyal, M., Darżynkiewicz, Z., & Dai, W. H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513156200 · Cited by 60 · see citing works

RNAi screening of the kinome identifies modulators of cisplatin response in ovarian cancer cells

Arora, S., Bisanz, K. M., Peralta, L. A., Basu, G. D., Choudhary, A. K., Tibes, R., & Azorsa, D. O. (2010) · Gynecologic Oncology · doi:10.1016/j.ygyno.2010.05.006 · Cited by 59 · see citing works

pERK 1/2 inhibit Caspase‐8 induced apoptosis in cancer cells by phosphorylating it in a cell cycle specific manner

Mandal, R., Raab, M., Matthess, Y., Becker, S., Knecht, R., & Strebhardt, K. (2013) · Molecular Oncology · doi:10.1016/j.molonc.2013.11.003 · Cited by 52 · see citing works

Efficient internalization of the polo-box of polo-like kinase 1 fused to an Antennapedia peptide results in inhibition of cancer cell proliferation.

Yuan, J., Krämer, A., Eckerdt, F., Kaufmann, M., & Strebhardt, K. (2002) · PubMed · Cited by 45 · see citing works

SLP-65 Phosphorylation Dynamics Reveals a Functional Basis for Signal Integration by Receptor-proximal Adaptor Proteins

Oellerich, T., Grønborg, M., Neumann, K., Hsiao, H., Urlaub, H., & Wienands, J. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800567-mcp200 · Cited by 43 · see citing works

Plk1: unexpected roles in DNA replication

Mandal, R., & Strebhardt, K. (2013) · Cell Research · doi:10.1038/cr.2013.130 · Cited by 39 · see citing works

Apoptotic rate: A new indicator for the quantification of the incidence of apoptosis in cell cultures

I, A. P., Díaz, D., Barcenilla, H., García‐Suárez, J., Reyes, E., Monserrat, J., Antonio, E. S., Melero, D., de la Hera, A., Órfão, A., et al. (2002) · Cytometry · doi:10.1002/cyto.10132 · Cited by 39 · see citing works

Dbf4 Regulates the Cdc5 Polo-like Kinase through a Distinct Non-canonical Binding Interaction

Chen, Y.-C., & Weinreich, M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.155242 · Cited by 38 · see citing works

Investigation on PLK2 and PLK3 substrate recognition

Salvi, M., Trashi, E., Cozza, G., Franchin, C., Arrigoni, G., & Pinna, L. A. (2012) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2012.07.003 · Cited by 38 · see citing works

Quantitative chemical proteomics reveals a Plk1 inhibitor-compromised cell death pathway in human cells

Raab, M., Pachl, F., Krämer, A., Kurunci‐Csacsko, E., Dötsch, C., Knecht, R., Becker, S., Küster, B., & Strebhardt, K. (2014) · Cell Research · doi:10.1038/cr.2014.86 · Cited by 18 · see citing works

Lymphocyte signaling: Adapting new adaptors

Rudd, C. E. (1998) · Current Biology · doi:10.1016/s0960-9822(07)00505-2 · Cited by 17 · see citing works

Erratum to: mRNA turnover rate limits siRNA and microRNA efficacy

Larsson, E., Sander, C., & Marks, D. S. (2010) · Molecular Systems Biology · doi:10.1038/msb.2010.113 · Cited by 12 · see citing works

Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018.

Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680 · see citing works

Caspase‐8: regulating life and death

Tummers, B., & Green, D. R. (2017) · Immunological Reviews · doi:10.1111/imr.12541 · Cited by 754 · see citing works

Caspase-8: The double-edged sword

Mandal, R., Compte, J., Kostova, I., Becker, S., & Strebhardt, K. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188357 · Cited by 252 · see citing works

Prolyl isomerase Pin1: a promoter of cancer and a target for therapy

Chen, Y., Wu, Y., Yang, H., Li, X., Jie, M., Hu, C.-J., Wu, Y., Yang, S., & Yang, Y. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0844-y · Cited by 156 · see citing works

Post-translational Modification of Caspases: The Other Side of Apoptosis Regulation

Zamaraev, A. V., Kopeina, G. S., Prokhorova, E. A., Zhivotovsky, B., & Lavrik, I. N. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.01.003 · Cited by 150 · see citing works

Human papilloma virus load and PD-1/PD-L1, CD8 + and FOXP3 in anal cancer patients treated with chemoradiotherapy: Rationale for immunotherapy

Balermpas, P., Martin, D., Wieland, U., Rave‐Fränk, M., Strebhardt, K., Rödel, C. M., Fokas, E., & Rödel, F. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1288331 · Cited by 106 · see citing works

Berberine associated photodynamic therapy promotes autophagy and apoptosis via ROS generation in renal carcinoma cells

Lopes, T. Z., de Moraes, F. R., Tedesco, A. C., Arni, R. K., Rahal, P., & Calmon, M. F. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109794 · Cited by 93 · see citing works

Caspase-8 in inflammatory diseases: a potential therapeutic target

Zhang, W., Zhu, C., Liao, Y., Zhou, M., Xu, W., & Zou, Z. (2024) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-024-00646-x · Cited by 97 · see citing works

Non-mitotic functions of polo-like kinases in cancer cells

Raab, C. A., Raab, M., Becker, S., & Strebhardt, K. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188467 · Cited by 80 · see citing works

Controlling Cell Death through Post-translational Modifications of DED Proteins

Seyrek, K., Ivanisenko, N. V., Richter, M., Hillert-Richter, L. K., König, C., & Lavrik, I. N. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.02.006 · Cited by 67 · see citing works

LINC00115 promotes chemoresistant breast cancer stem-like cell stemness and metastasis through SETDB1/PLK3/HIF1α signaling

Luo, F., Zhang, M., Sun, B., Xu, C., Yang, Y., Zhang, Y., Li, S., Chen, G., Chen, C., Li, Y., et al. (2024) · Molecular Cancer · doi:10.1186/s12943-024-01975-3 · Cited by 64 · see citing works

Caspase-8 function, and phosphorylation, in cell migration

Keller, N., Ozmadenci, D., Ichim, G., & Stupack, D. G. (2018) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2018.01.009 · Cited by 58 · see citing works

Blocking Mitotic Exit of Ovarian Cancer Cells by Pharmaceutical Inhibition of the Anaphase-Promoting Complex Reduces Chromosomal Instability

Raab, M., Sanhaji, M., Zhou, S., Rödel, F., El‐Balat, A., Becker, S., & Strebhardt, K. (2019) · Neoplasia · doi:10.1016/j.neo.2019.01.007 · Cited by 42 · see citing works

Molecular Markers to Predict Prognosis and Treatment Response in Uterine Cervical Cancer

Fleischmann, M., Chatzikonstantinou, G., Fokas, E., Wichmann, J., Christiansen, H., Strebhardt, K., Rödel, C. M., Tselis, N., & Rödel, F. (2021) · Cancers · doi:10.3390/cancers13225748 · Cited by 41 · see citing works

The immune microenvironment and HPV in anal cancer: Rationale to complement chemoradiation with immunotherapy

Martin, D., Rödel, F., Balermpas, P., Rödel, C. M., & Fokas, E. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.05.001 · Cited by 41 · see citing works

Bottom-up assembly of target-specific cytotoxic synthetic cells

Bücher, J. E. H., Staufer, O., Ostertag, L., Mersdorf, U., Platzman, I., & Spatz, J. P. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121522 · Cited by 34 · see citing works

JWA regulates TRAIL-induced apoptosis via MARCH8-mediated DR4 ubiquitination in cisplatin-resistant gastric cancer cells

Wang, Q., Chen, Q., Zhu, L., Chen, M., Xu, W., Panday, S., Wang, Z., Li, A., Røe, O. D., Chen, R., et al. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.57 · Cited by 33 · see citing works

Cellular demolition: Proteins as molecular players of programmed cell death

Dhuriya, Y. K., Sharma, D., & Naik, A. A. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.07.113 · Cited by 26 · see citing works

Caspase-8 and Tyrosine Kinases: A Dangerous Liaison in Cancer

Contadini, C., Ferri, A., Cirotti, C., Stupack, D. G., & Barilà, D. (2023) · Cancers · doi:10.3390/cancers15133271 · Cited by 21 · see citing works

Modulation of the Allosteric Communication between the Polo-Box Domain and the Catalytic Domain in Plk1 by Small Compounds

Raab, M., Sanhaji, M., Pietsch, L., Béquignon, I., Herbrand, A. K., Süß, E., Gande, S. L., Caspar, B., Kudlinzki, D., Saxena, K., et al. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.7b01078 · Cited by 21 · see citing works

Cell death classification: A new insight based on molecular mechanisms

Dehghan, S., Kheshtchin, N., Hassannezhad, S., & Soleimani, M. (2023) · Experimental Cell Research · doi:10.1016/j.yexcr.2023.113860 · Cited by 18 · see citing works

The Role of Post-Translational Modifications in Necroptosis

Xiao, H., Han, Z., Xu, M., Gao, X., Qiu, S., Ren, N., Yi, Y., & Zhou, C. (2025) · Biomolecules · doi:10.3390/biom15040549 · Cited by 15 · see citing works

Sequential Targeting of PLK1 and PARP1 Reverses the Resistance to PARP Inhibitors and Enhances Platin-Based Chemotherapy in BRCA-Deficient High-Grade Serous Ovarian Cancer with KRAS Amplification

Gasimli, K., Raab, M., Rad, M. T., Kurunci‐Csacsko, E., Becker, S., Strebhardt, K., & Sanhaji, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810892 · Cited by 15 · see citing works

Phosphorylation of PLK3 Is Controlled by Protein Phosphatase 6

Aquino-Perez, C., Palek, M., Stolařová, L., von Morgen, P., & Macůrek, L. (2020) · Cells · doi:10.3390/cells9061506 · Cited by 14 · see citing works

Prognostic impact of RITA expression in patients with anal squamous cell carcinoma treated with chemoradiotherapy

Rödel, F., Steinhäuser, K., Kreis, N., Friemel, A., Martin, D., Wieland, U., Rave‐Fränk, M., Balermpas, P., Fokas, E., Louwen, F., et al. (2017) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2017.10.028 · Cited by 13 · see citing works

The role of polo‐like kinase 3 in the response of BRAF‐mutant cells to targeted anticancer therapies

Babagana, M., Kichina, J. V., Slabodkin, H., Johnson, S., Maslov, A., Brown, L., Attwood, K., Nikiforov, M. A., & Kandel, E. S. (2020) · Molecular Carcinogenesis · doi:10.1002/mc.23123 · Cited by 12 · see citing works

Polo-like kinase 3 and phosphoT273 caspase-8 are associated with improved local tumor control and survival in patients with anal carcinoma treated with concomitant chemoradiotherapy

Rödel, F., Martin, D., Helmke, C., Balermpas, P., Fokas, E., Wieland, U., Rave‐Fränk, M., Kitz, J., Matthess, Y., Raab, M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10801 · Cited by 12 · see citing works

The non-apoptotic function of Caspase-8 in negatively regulating the CDK9-mediated Ser2 phosphorylation of RNA polymerase II in cervical cancer

Mandal, R., Raab, M., Rödel, F., Krämer, A., Kostova, I., Peña‐Llopis, S., Medici, G., Häupl, B., Oellerich, T., Gasimli, K., et al. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04598-3 · Cited by 12 · see citing works

Spatio-temporal control of mitosis using light via a Plk1 inhibitor caged for activity and cellular permeability

von Glasenapp, V., Almeida, A. C., Chang, D., Gasic, I., Winssinger, N., & Gotta, M. (2025) · Nature Communications · doi:10.1038/s41467-025-56746-5 · Cited by 11 · see citing works

The Crosstalk of Apoptotic and Non-Apoptotic Signaling in CD95 System

Seyrek, K., Espe, J., Reiss, E., & Lavrik, I. N. (2024) · Cells · doi:10.3390/cells13211814 · Cited by 11 · see citing works

miR‐150‐504‐519d inhibits the growth of human colorectal cancer cell line SW48 and downregulates c‐FLIP receptor

Rong, G., Yang, X., Wu, H.-R., & Wu, Y. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28073 · Cited by 9 · see citing works

Association of Polo-Like Kinase 3 and PhosphoT273 Caspase 8 Levels With Disease-Related Outcomes Among Cervical Squamous Cell Carcinoma Patients Treated With Chemoradiation and Brachytherapy

Fleischmann, M., Martin, D., Peña‐Llopis, S., Oppermann, J., von der Grün, J., Diefenhardt, M., Chatzikonstantinou, G., Fokas, E., Rödel, C. M., Strebhardt, K., et al. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00742 · Cited by 7 · see citing works

TUBA1A licenses APC /C‐mediated mitotic progression to drive glioblastoma growth by inhibiting PLK3

Wen, J., Wang, Q., Zhang, W., & Wang, W. (2023) · FEBS Letters · doi:10.1002/1873-3468.14764 · Cited by 6 · see citing works

Nardilysin-regulated scission mechanism activates polo-like kinase 3 to suppress the development of pancreatic cancer

Fu, J., Ling, J., Li, C.-F., Tsai, C.-L., Yin, W., Hou, J., Chen, P.-H., Cao, Y., Kang, Y., Sun, Y., et al. (2022) · bioRxiv · doi:10.1038/s41467-024-47242-3 · Cited by 3 · see citing works

Prognostic Impact of Caspase-8, CDK9 and Phospho-CDK9 (Thr 186) Expression in Patients with Uterine Cervical Cancer Treated with Definitive Chemoradiation and Brachytherapy

Fleischmann, M., Mandal, R., Kostova, I., Raab, M., Sanhaji, M., Hehlgans, S., Diefenhardt, M., Rödel, C. M., Fokas, E., Strebhardt, K., et al. (2022) · Cancers · doi:10.3390/cancers14225500 · Cited by 4 · see citing works

Emerging advances and future opportunities in the molecular and therapeutic landscape of anal cancer

Rödel, F., Fleischmann, M., Diefenhardt, M., Dapper, H., Hoffmann, A., Rödel, C. M., Martin, D., & Fokas, E. (2025) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-025-01025-x · Cited by 2 · see citing works

Caspases: Regulatory Mechanisms and Their Implications in Pathogenesis and Therapeutics

Parui, A. L., & Bose, K. (2017) · Springer eBooks · doi:10.1007/978-981-10-6141-7_18 · Cited by 2 · see citing works

Polo-like kinases as immune modulators: a new frontier in cancer immunotherapy

Jaiswal, T., Chhabra, G., & Ahmad, N. (2025) · Trends in cancer · doi:10.1016/j.trecan.2025.08.003 · Cited by 1 · see citing works

In Vitro Evaluation of Cytotoxic Effects of Nickel Oxide Nanoparticles on Human Neuroblastoma Cell Line (SH-SY5Y)

tehrania, M. H., Ale‐Ebrahim, M., Falahati, M., & Zarabiyan, S. (2021) · Qom Univ Med Sci J · doi:10.52547/qums.14.11.20 · Cited by 1 · see citing works

Activation and Stabilization of the Caspase-8 Survivalsome is Indispensable for Functional Toll-like Receptor 4 Dependent Signaling in Septic Neutrophils

Gupta, S. (2020) · TSpace (University of Toronto) · Cited by 1 · see citing works

Death Receptors

Krammer, P. H., Pietkiewicz, S., & Lavrik, I. N. (2016) · Wiley eBooks · doi:10.1002/9780470015902.a0021571.pub2

Additional file 1 of LINC00115 promotes chemoresistant breast cancer stem-like cell stemness and metastasis through SETDB1/PLK3/HIF1α signaling

Luo, F., Zhang, M., Sun, B., Xu, C., Yang, Y., Zhang, Y., Li, S., Chen, G., Chen, C., Li, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25464942

New Insights Into the Role of Polo‐Like Kinase 3 in Lung Tumorigenesis

Li, C., Samad, A., Ostrowski, C., Alam, S. M. S., Yin, C., Ayyamperumal, S., Chen, J., Zhong, M., Huang, W., Wang, Y., et al. (2026) · Journal of Cellular Biochemistry · doi:10.1002/jcb.70084

Mécanisme d'activation du récepteur pro-apoptotique à domaine de mort dr5 par des peptides agonistes multivalents : une approche par mutagenèse dirigée et études d’interaction par divers techniques biophysiques

Sobron, L. (2023) · doi:10.70675/921274c5z3f19z4c0dzaaaaz0e2b30de4c30

Sequential Cdk1 and Plk1 phosphorylation of caspase‐8 triggers apoptotic cell death during mitosis

Matthess, Y., Raab, M., Knecht, R., Becker, S., & Strebhardt, K. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2013.12.013 · Cited by 71 · see citing works

Cellular stimulation via CD95 involves activation of phospho-inositide-3-kinase

Gulbins, E., Hermisson, M., Brenner, B., Grassmé, H., Linderkamp, O., DICHGANS, J., Weller, M., & Lang, F. J. W. (1998) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s004240050551 · Cited by 19 · see citing works

Tyrosine phosphorylation and CD95: A FAScinating switch

Sancho-Martinez, I., & Martín-Villalba, A. (2009) · Cell Cycle · doi:10.4161/cc.8.6.7906 · Cited by 53 · see citing works

L'inhibition de la voie Phosphoinositide-3 kinase (PI3K)/AKT induit un signal apoptotique via la redistribution du récepteur de mort CD95 dans les radeaux lipidiques

Pizon, M. (2010) · doi:10.70675/cf6c6a99zbcb8z48e9z966fzbb10d5263fb0

Phosphatidylinositol 3′-Kinase Blocks CD95 Aggregation and Caspase-8 Cleavage at the Death-Inducing Signaling Complex by Modulating Lateral Diffusion of CD95

Varadhachary, A. S., Edidin, M. A., Hanlon, A. M., Peter, M. E., Krammer, P. H., & Salgame, P. R. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6564 · Cited by 88 · see citing works